Seeker Biologics
The business, the turning points, and the decisions behind them.
01 / WHAT IT BUILT
What the company did
Seeker Biologics, formerly Fleet Therapeutics, researched biologic medicines for autoimmune, allergic and inflammatory diseases.
02 / Seeker Biologics FAILURE REASONS
Failure reasons
The company did not achieve its intended drug-discovery goals. A former research leader described scientific progress and timing as falling short of expectations in a difficult market. The available account does not identify a specific failed human trial.
03 / EVENT HISTORY
Events in the structured record
- Drug-discovery operation closed
The company ended operations in April after falling short of its research goals.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Biologic drug discovery pursued
- 02
Research fell short of intended goals and timing
- 03
Company ended operations